SynBiotic SE/€SBX
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About SynBiotic SE
SynBiotic SE is a German company specializing in the research, development, production, and marketing of cannabinoid and terpene-based products aimed at addressing conditions such as pain, sleep deprivation, and anxiety. Its product portfolio includes hemp-derived dietary supplements, cosmetics, medical cannabis products, and recreational cannabis items, marketed under brands like Hempamed, Princess Stardust, The Hempany, and Hempamed Rx. Originally known as Ledgertech SE, the company rebranded to SynBiotic SE and is headquartered in Munich, Germany. Through strategic acquisitions, such as the 2024 purchase of WEECO Pharma GmbH, SynBiotic has expanded its presence in the European medical cannabis market. The company operates across the entire value chain, from cultivation to retail, positioning itself as a comprehensive player in the hemp and cannabis industry. (,)
Ticker
€SBX
Sector
Primary listing
XETRA
Employees
55
Headquarters
Website
SynBiotic SE Metrics
BasicAdvanced
€24M
-
-€2.24
4.54
-
Price and volume
Market cap
€24M
Beta
4.54
52-week high
€3.73
52-week low
€2.87
Average daily volume
10K
Financial strength
Current ratio
0.814
Quick ratio
0.328
Long term debt to equity
18.878
Total debt to equity
27.084
Interest coverage (TTM)
-43.09%
Profitability
EBITDA (TTM)
-7.545
Gross margin (TTM)
39.01%
Net profit margin (TTM)
-275.31%
Operating margin (TTM)
-217.87%
Effective tax rate (TTM)
1.14%
Revenue per employee (TTM)
€70,000
Management effectiveness
Return on assets (TTM)
-13.92%
Return on equity (TTM)
-61.58%
Valuation
Price to revenue (TTM)
3.798
Price to book
1.14
Price to tangible book (TTM)
-2.5
Price to free cash flow (TTM)
-4.983
Free cash flow yield (TTM)
-20.07%
Free cash flow per share (TTM)
-0.62
Growth
Revenue change (TTM)
-52.71%
Earnings per share change (TTM)
-62.48%
3-year revenue growth (CAGR)
-10.97%
3-year earnings per share growth (CAGR)
58.39%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SynBiotic SE stock?
SynBiotic SE (SBX) has a market cap of €24M as of August 23, 2025.
What is the P/E ratio for SynBiotic SE stock?
The price to earnings (P/E) ratio for SynBiotic SE (SBX) stock is 0 as of August 23, 2025.
Does SynBiotic SE stock pay dividends?
No, SynBiotic SE (SBX) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next SynBiotic SE dividend payment date?
SynBiotic SE (SBX) stock does not pay dividends to its shareholders.
What is the beta indicator for SynBiotic SE?
SynBiotic SE (SBX) has a beta rating of 4.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.